Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/25 17:57 | 2/13/25 | ZVRA | Health | Drug | Pharmaceutical Preparations | Sangiovanni Timothy J. | FL | O | SVP,Fina | S | -24 | 7.86 | 0 | -3 | -16 | 16 | D | ||||||||||||||
2/14/25 17:55 | 2/13/25 | ZVRA | Health | Drug | Pharmaceutical Preparations | Schafer Joshua | FL | O | CCO,EVP, | S | -83 | 7.86 | 0 | -11 | -26 | 29 | D | ||||||||||||||
2/14/25 17:55 | 2/13/25 | ZVRA | Health | Drug | Pharmaceutical Preparations | Clifton R. Laduane | FL | O | CFO,Trea | S | -86 | 7.86 | 0 | -11 | -18 | 51 | D | ||||||||||||||
2/14/25 17:54 | 2/13/25 | ZVRA | Health | Drug | Pharmaceutical Preparations | McFarlane Neil F. | FL | DO | P,CEO | S.m | -727 | 7.92 | 0 | -92 | -32 | 192 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |